Customer Discovery · Case Study
Reply rates from <1% to 10.5% via cold outbound.
- Industry
- Healthcare
- Funding Stage
- Series A
- Engagement
- Customer Discovery
CrelioHealth is an India-based cloud LIS and RIS platform that lets laboratory staff, doctors and patients access and manage medical information in one place.
They have scaled to serve 2,500-plus labs worldwide.
The Challenge
Crelio Health sought to enter the U.S. market after finding success in Southeast Asia. They needed to understand buyer profile differences between Asia and the U.S., plus identify unmet customer needs to inform their go-to-market strategy. The independent lab space presented unique prospecting obstacles, making it difficult to generate discoverable high-fit prospects.
The Solution
JJELLYFISH developed a specialized prospecting methodology for the independent lab sector. They executed structured outbound campaigns with personalized targeting, conducting discovery meetings with senior lab operations leaders to assess market maturity, technology sophistication, and existing pain points.
The Results
The campaign achieved 130% of discovery meeting targets, improved reply rates from under 1% to over 10.5%, and generated a 7% interest rate via cold outbound. Crelio Health subsequently adopted JJELLYFISH's model for testing alternative product lines.
Abhimanyu Bhosale, Co-Founder & CEOWe really learned a lot from JJELLYFISH's approach towards the U.S. market - right from day one. The way they researched the ICP, created personalized email campaigns, conducted meetings... it was all structured very well.